The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Monoamine transporters and psychostimulant drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,151
Neurotransmitter Transporters: Recent Progress
Amara, S. G., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,082
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Self-citationRossetti, Z. L., Hmaidan, Y., & Gessa, G. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90706-a · Cited by 521
Postcocaine anhedonia. An animal model of cocaine withdrawal.
Markou, A., & Koob, G. F. (1991) · PubMed · Cited by 505
From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters
Rudnick, G., & Clark, J. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90109-s · Cited by 469
A Double Epidemic: Crystal Methamphetamine Drug Use in Relation to HIV Transmission
Halkitis, P. N., Parsons, J. T., & Stirratt, M. J. (2001) · Journal of Homosexuality · doi:10.1300/j082v41n02_02 · Cited by 434
Neurotransmitter Transporters in the Central Nervous System
Masson, J., Sagné, C., Hamon, M., & El Mestikawy, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01414-5 · Cited by 416
Molecular Physiology of Norepinephrine and Serotonin Transporters
Blakely, R. D., De Felice, L. J., & Hartzell, H. C. (1994) · Journal of Experimental Biology · doi:10.1242/jeb.196.1.263 · Cited by 404
Kuczenski, R., Segal, D., Cho, A., & Melega, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01308.1995 · Cited by 376
Nicotine Medications for Smoking Cessation
Henningfield, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331807 · Cited by 352
Neurotransmitter transporters as molecular targets for addictive drugs
Amara, S. G., & Sonders, M. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00068-4 · Cited by 289
Cocaine psychoses: a continuum model
(1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.3.225 · Cited by 288
Parsons, L. H., Smith, A. D., & Justice, J. B. (1991) · Synapse · doi:10.1002/syn.890090109 · Cited by 260
Neurotransmitter transporters : structure, function, and regulation
Reith, M. E. A. (2002) · Humana Press eBooks · Cited by 255
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243
Parsons, L. H., Koob, G. F., & Weiss, F. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10596-x · Cited by 218
Rothman, R. B., Ayestas, M. A., Dersch, C. M., & Baumann, M. H. (1999) · Circulation · doi:10.1161/01.cir.100.8.869 · Cited by 213
Self-citationHigh‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain
Boja, J. W., Mitchell, W. M., Patel, A., Kopajtic, T. A., Carroll, F. I., Lewin, A. H., Abraham, P., & Kuhar, M. J. (1992) · Synapse · doi:10.1002/syn.890120104 · Cited by 212
Karch, S. B., Segura, J., Boja, J. W., Wetli, C., Wolff, K., Heishman, S. J., Benowitz, N. L., Caplan, Y. H., Cone, E. J., Jones, A. W., et al. (1997) · Routledge eBooks · doi:10.1201/9781420048292 · Cited by 196
Replacement Medication for Cocaine Dependence: Methylphenidate
Grabowski, J., Roache, J. D., Schmitz, J. M., Rhoades, H., Creson, D., & Korszun, A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199712000-00008 · Cited by 191
Carroll, F. I., Kotian, P., Dehghani, A., Gray, J. L., Kuzemko, M. A., Parham, K. A., Abraham, P., Lewin, A. H., Boja, J. W., & Kuhar, M. J. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00002a020 · Cited by 187
Therapeutic and adverse actions of serotonin transporter substrates
Rothman, R. B., & Baumann, M. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00234-6 · Cited by 183
Self-citationMelega, W. P., Williams, A. E., Schmitz, D. A., DiStefano, E. W., & Cho, A. K. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10706-4 · Cited by 169
Neurochemical changes in cocaine withdrawal
Kuhar, M. J., & Pilotte, N. S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10024-9 · Cited by 159
Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding
Cunningham, K. A., Paris, J. M., & Goeders, N. E. (1992) · Synapse · doi:10.1002/syn.890110204 · Cited by 152
Neurochemical Correlates of Cocaine and Ethanol Self‐Administrationa
Weiss, F., Hurd, Y. L., Ungerstedt, U., Markou, A., Plotsky, P. M., & Koob, G. F. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25970.x · Cited by 149
Substitution Pharmacotherapies for Opioid Addiction: From Methadone to LAAM and Buprenorphine
Ling, W. W., Rawson, R. A., & Compton, M. A. (1994) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1994.10472259 · Cited by 135
Rothman, R. B., & Baumann, M. H. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00669-4 · Cited by 134
Self-citationPsychiatric Comorbidity of Methamphetamine Dependence in a Forensic Sample
Kalechstein, A. D., Newton, T. F., Longshore, D. L., Anglin, M. D., van Gorp, W. G., & Gawin, F. H. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.4.480 · Cited by 127
Opiates, opioids and addiction.
Kreek, M. J. (1996) · PubMed · Cited by 126
Neurotransmitter Transporters: Three Important Gene Families for Neuronal Function
Uhl, G. R., & Johnson, P. S. (1994) · Journal of Experimental Biology · doi:10.1242/jeb.196.1.229 · Cited by 125
Marzuk, P. M., Tardiff, K. J., Leon, A. C., Stajić, M., Morgan, E. B., & Mann, J. J. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.3.371 · Cited by 123
Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment
Robertson, M. W., Leslie, C. A., & Bennett, J. P. (1991) · Brain Research · doi:10.1016/0006-8993(91)90451-z · Cited by 123
Staley, J. K., Basile, M. J., Flynn, D. D., & Mash, D. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62020549.x · Cited by 114
Baumann, M. H., AYESTAS, M. A., Dersch, C. M., Brockington, A., Rice, K. C., & Rothman, R. B. (2000) · Synapse · Cited by 113
Self-citationRothman, R. B., Reid, A. A., Mahboubi, A., Kim, C.-H., COSTA, B. R. D., Jacobson, A. E., & Rice, K. C. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10929-2 · Cited by 112
Self-citationExtracellular cocaine and dopamine concentrations are linearly related in rat striatum
Nicolaysen, L. C., Pan, H., & Justice, J. B. (1988) · Brain Research · doi:10.1016/0006-8993(88)90234-x · Cited by 112
Chen, N., & Reith, M. E. A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051701.x · Cited by 103
GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.
Baumann, M. H., Char, G. U., COSTA, B. R. D., Rice, K. C., & Rothman, R. B. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24002-2 · Cited by 102
Self-citationLin, D. C.-H., Koob, G. F., & Markou, A. (1999) · Psychopharmacology · doi:10.1007/s002130051060 · Cited by 95
Li, M., Yan, Q., Coffey, L. L., & Reith, M. E. A. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020559.x · Cited by 95
Cocaine Abuse in North America: A Milestone in History
Das, G. C. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb04661.x · Cited by 90
Comparison of behavior maintained by infusions of eight phenylethylamines in baboons
Griffiths, R. R., Winger, G. D., Brady, J. V., & Snell, J. D. (1976) · Psychopharmacology · doi:10.1007/bf00426841 · Cited by 86
Baumann, M. H., & Rothman, R. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00123-1 · Cited by 86
Self-citationCocaine and methamphetamine: Differential addiction rates.
Castro, F. G., Barrington, E. H., Walton, M. A., & Rawson, R. A. (2000) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.14.4.390 · Cited by 83
Monoaminergic Regulation of Neuroendocrine Function and Its Modification by Cocaine
Levy, A. D., Baumann, M. H., & de Kar, L. D. V. (1994) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1994.1006 · Cited by 78
Self-citationBoja, J. W., Kuhar, M. J., Kopajtic, T. A., Yang, E., Abraham, P., Lewin, A. H., & Carroll, F. I. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a021 · Cited by 77
Rothman, R. B., Clark, R. D., Partilla, J. S., & Baumann, M. H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049684 · Cited by 76
Self-citationCarroll, F. I., Abraham, P., Lewin, A. H., Parham, K., Boja, J. W., & Kuhar, M. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00091a019 · Cited by 73
Rothman, R. B., Katsnelson, M., Vu, N., Partilla, J. S., Dersch, C. M., Blough, B. E., & Baumann, M. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01830-7 · Cited by 73
Self-citationMunzar, P., Baumann, M. H., Shoaib, M. C., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050836 · Cited by 71
Self-citationAmphetamine-like effects of anorectics and related compounds in pigeons.
Evans, S. M., & Johanson, C. E. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00192-2 · Cited by 71
Boja, J. W., Cadet, J. L., Kopajtic, T. A., et al. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08626-2 · Cited by 68
The Rate Hypothesis and Agonist Substitution Approaches to Cocaine Abuse Treatment
Gorelick, D. A. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60914-x · Cited by 67
Depression as an Antecedent of Frequency of Intravenous Drug Use in an Urban, Nontreatment Sample
Latkin, C. A., & Mandell, W. (1993) · International Journal of the Addictions · doi:10.3109/10826089309062202 · Cited by 61
Rothman, R. B., Cadet, J. L., Akunne, H. C., Silverthorn, M. L., Baumann, M. H., Carroll, F. I., Rice, K. C., COSTA, B. R. D., Partilla, J. S., & Wang, J. B. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22365-5 · Cited by 60
Self-citationWood, D. M., & Emmett-Oglesby, M. (1988) · Psychopharmacology · doi:10.1007/bf00181948 · Cited by 57
Modulation of intravenous cocaine effects by chronic oral cocaine in humans
WALSH, S. L., Haberny, K. A., & Bigelow, G. E. (2000) · Psychopharmacology · doi:10.1007/s002130000439 · Cited by 56
Evaluation of Phentermine and Fenfluramine, Alone and in Combination, in Normal, Healthy Volunteers
Brauer, L. H. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00113-r · Cited by 53
Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction
Rothman, R. B., Elmer, G. I., Shippenberg, T. S., Rea, W. P., & Baumann, M. H. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08222.x · Cited by 50
Self-citationPhentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys
Glowa, J. R., Rice, K. C., Matecka, D., & Rothman, R. B. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00006 · Cited by 48
Self-citationConnolly, H. M., & McGoon, M. D. (1999) · Current Problems in Cardiology · doi:10.1016/s0146-2806(99)90013-0 · Cited by 46
Blough, B. E., Abraham, P., Mills, A. C., Lewin, A. H., Boja, J. W., Scheffel, U., Kuhar, M. J., & Carroll, F. I. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970492z · Cited by 44
Appetite Suppressants as Agonist Substitution Therapies for Stimulant Dependence
Rothman, R. B., Blough, B. E., & Baumann, M. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04155.x · Cited by 42
Self-citationDrug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis.
Batki, S. L. (1990) · PubMed Central · Cited by 39
(1995) · PubMed · Cited by 39
Inhibition of cocaine self-administration by fluoxetine or d-fenfluramine combined with phentermine
Glatz, A. C., Ehrlich, M. E., Bae, R. S., Clarke, M. J., Quinlan, P. A., Brown, E. C., Rada, P. V., & Hoebel, B. G. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00657-8 · Cited by 37
Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters
Yu, H., Rothman, R. B., Dersch, C. M., Partilla, J. S., & Rice, K. C. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00210-8 · Cited by 36
Self-citationWojnicki, F. H. E., Rothman, R. B., Rice, K. C., & Glowa, J. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37989-3 · Cited by 35
Self-citationDiethylpropion Pharmacotherapeutic Adjuvant Therapy for Inpatient Treatment of Cocaine Dependence
Alim, T. N., Rosse, R. B., Vocci, F. J., Lindquist, T., & Deutsch, S. I. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199504000-00009 · Cited by 34
Stafford, D. A., LeSage, M. G., Rice, K. C., & Glowa, J. R. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00158-7 · Cited by 32
Rothman, R. B., Gendron, T. M., & Hitzig, P. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90086-8 · Cited by 32
Self-citationDersch, C. M., Akunne, H. C., Partilla, J. S., Char, G. U., de Costa, B. R., Rice, K. C., Carroll, F. I., & Rothman, R. B. (1994) · Neurochemical Research · doi:10.1007/bf00966817 · Cited by 31
Self-citationThe combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial
Kampman, K. M., Rukstalis, M. R., Pettinati, H. M., Muller, E., Acosta, T., Gariti, P., Ehrman, R., & O’Brien, C. P. (2000) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(99)00076-8 · Cited by 26
Pepper, J., Baumann, M. H., AYESTAS, M. A., & Rothman, R. B. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00013-4 · Cited by 19
Self-citationPrevalence and Treatment Models for Addiction in Psychiatric Populations
Miller, N. S. (1994) · Psychiatric Annals · doi:10.3928/0048-5713-19940801-07 · Cited by 19
Assessment of reinforcing properties of amphetamine analogues in self-administering rats.
Götestam, K. G., & Be, A. (1975) · PubMed · Cited by 13
Opportunities for Medication Development in Obesity
Rothman, R. B., & Carroll, F. I. (2000) · Drug Development Research · Cited by 2
Self-citation
Cited by
Involvement of the endocannabinoid system in drug addiction
Maldonado, R., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 580
Han, D. D., & Gu, H. H. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-6 · Cited by 419
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 410
Baumann, M. H., Partilla, J. S., Lehner, K. R., Thorndike, E. B., Hoffman, A. F., Holy, M., Rothman, R. B., Goldberg, S. R., Lupica, C. R., Sitte, H. H., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.204 · Cited by 408
Self-citationThe Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393
Metadata
- Authors
- Rothman, R. B., & Baumann, M. H.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 479
- Issue
- 1-3
- Pages
- 23-40
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2090563027
- Cited by
- 502
- References
- 81
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.